Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Evaluating credit card rewards is crucial for maximizing value. Learn which options provide the best returns for your spending.
28,180 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Analysts issued fresh price targets on nine stocks, signaling divergent views as U.S. markets contend with rate uncer...
Oil sits around $107.70 a barrel on May 11, 2026, supported by producer discipline and steady demand. The move could ...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
Hyperliquid's new ETFs drew nearly $50 million in the first week, lifting the token price above $50 and signaling gro...
A couple with a $240,000 annual income discovers a hidden transfer to the husband's parents, prompting questions abou...
The CLARITY Act aims to separate crypto oversight between the SEC and CFTC while probing foreign adversary risks. Cri...
XRP breached the $1 support, prompting a renewed look at downside risk and potential relief rallies. This article map...
Bitcoin faces renewed pressure around the $60,000 zone with on-chain data suggesting more coins moving to exchanges. ...
As AI hardware demand strengthens, the buy everything ai strategy draws renewed attention. AIQ has posted double-digi...
Oil prices tumbled to their lowest levels since early March as a tentative Iran agreement raised hopes of easing tank...
A U.S. federal court permanently barred celsius founder alex mashinsky from trading in CFTC-regulated markets, resolv...